| First Author | El Ouaamari A | Year | 2013 |
| Journal | Cell Rep | Volume | 3 |
| Issue | 2 | Pages | 401-10 |
| PubMed ID | 23375376 | Mgi Jnum | J:196316 |
| Mgi Id | MGI:5487721 | Doi | 10.1016/j.celrep.2013.01.007 |
| Citation | El Ouaamari A, et al. (2013) Liver-derived systemic factors drive beta cell hyperplasia in insulin-resistant states. Cell Rep 3(2):401-10 |
| abstractText | Integrative organ crosstalk regulates key aspects of energy homeostasis, and its dysregulation may underlie metabolic disorders such as obesity and diabetes. To test the hypothesis that crosstalk between the liver and pancreatic islets modulates beta cell growth in response to insulin resistance, we used the liver-specific insulin receptor knockout (LIRKO) mouse, a unique model that exhibits dramatic islet hyperplasia. Using complementary in vivo parabiosis and transplantation assays, as well as in vitro islet culture approaches, we demonstrate that humoral, nonneural, non-cell-autonomous factor(s) induces beta cell proliferation in LIRKO mice. Furthermore, we report that a hepatocyte-derived factor(s) stimulates mouse and human beta cell proliferation in ex vivo assays, independent of ambient glucose and insulin levels. These data implicate the liver as a critical source of beta cell growth factor(s) in insulin-resistant states. |
